GoodRx推出专注于勃起功能障碍治疗的新订阅服务

2025-06-10 22:39

Shares of GoodRx (NASDAQ:GDRX) traded higher on Tuesday after the drug savings platform announced the launch of a new subscription service focused on treatments for erectile dysfunction (ED).
The new service comes with an online healthcare consultation and discreet home delivery, and it starts at $18 per month, with the final fee based on the prescribed ED medication, the company noted.
According to a new GDRX-commissioned survey, while nearly a third of U.S. men suffer from ED, less than 14% of them seek treatments due to factors such as inadequate payor coverage and social stigma.
“Designed to meet consumers where they are and remove common barriers such as high costs, long wait times, and inconvenience, this all-in-one solution offers a fast, discreet, and affordable option for ED treatment,” the company said.

More on GoodRx Holdings